A new clinical trial at The Ohio State University's Wexner Medical Center could change how doctors treat breast cancer. The trial involves targeted treatment going after an aggressive form of breast cancer, and it could be a game-changer. "This could really revolutionize the way women are treated with breast cancer," said Dr. Erin Macrae, of the OSU Comprehensive Breast Center. Macrae is leading the clinical trial, focusing on two new drugs to target specific ways triple negative breast cancer grows and spreads. This coverage resulted from pitching efforts by OSU Wexner Medical Center Public Affairs and Media Relations.